Farxiga, AstraZeneca’s SGLT2 inhibitor for type 2 diabetes, heart failure, and chronic kidney disease, carries a list price north of $600 for a 30-day supply. For an uninsured patient prescribed Farxiga long term, that is more than $7,000 a year, which is why the Farxiga patient assistance program exists. Run by AstraZeneca’s AZ&Me Prescription Savings Program, the Farxiga patient assistance program can deliver Farxiga at no cost to qualifying Americans for up to 12 months at a time. Our healthcare costs guide covers how programs like this fit into the broader savings landscape.
What the Farxiga Patient Assistance Program Provides
AstraZeneca operates AZ&Me, a 501(c)(3) patient assistance foundation that ships free AstraZeneca medications to eligible uninsured and Medicare Part D patients. Farxiga (dapagliflozin) is one of the medications covered through AZ&Me, alongside Brilinta, Symbicort, Crestor, and several oncology products. Approved patients receive 90-day shipments of Farxiga at no cost, with enrollment renewable annually.
The program is distinct from AstraZeneca’s Farxiga savings card, which is a commercial copay coupon aimed at privately insured patients. The savings card reduces your copay to as little as $0 but only if you have commercial insurance. The Farxiga patient assistance program, by contrast, is for people who cannot afford Farxiga at all because they have no insurance or because their Medicare plan leaves them with heavy out-of-pocket exposure.
Who Qualifies for the Farxiga Patient Assistance Program
AZ&Me sets income eligibility at or below 400% of the federal poverty level for uninsured applicants, which in 2026 works out to roughly $62,600 for a single-person household and $129,000 for a family of four based on HHS poverty guidelines. Medicare Part D patients have a slightly different threshold, and eligibility reviews consider annual out-of-pocket drug spending.
To qualify, you must be a US resident with a valid Farxiga prescription written by a licensed US physician. You must not have prescription drug insurance that covers Farxiga. Patients enrolled in Medicaid are typically directed to Medicaid, not AZ&Me. Medicare Part D patients can apply if they are not enrolled in full Extra Help. Commercially insured patients are steered to the Farxiga savings card instead.
How to Apply for the Farxiga Patient Assistance Program
The application process takes two to four weeks from submission to first shipment. Start at azandmeapp.com or call 1-800-292-6363 to request a paper enrollment form. The form has three sections: patient, prescriber, and attestation. You complete the patient section with household size, income, insurance status, and contact information.
Your prescribing physician completes the prescriber section with your diagnosis, Farxiga dose, and treatment plan, then signs. Both signatures are required. You also attach proof of household income, usually your most recent IRS Form 1040 or three months of pay stubs or Social Security benefit letters. Fax or mail the complete packet to the AZ&Me processing center at the address on the form.
AZ&Me reviews the application and notifies you and your physician of the decision. Approved patients receive their first 90-day supply of Farxiga within about three weeks, shipped to the prescriber’s office or to a designated pharmacy. The physician’s staff usually coordinates pickup and notifies you when it is ready.
What You Receive After Approval
Approved enrollees receive Farxiga at $0 cost for the duration of the enrollment period, typically 12 months. Refills arrive every 90 days. There are no shipping fees, copays, or application fees at any stage of the process. If your physician changes the dose or you switch between Farxiga tablet strengths, notify AZ&Me so your enrollment record stays current.
Roughly 60 days before your enrollment expires, AZ&Me mails a renewal notice. To continue receiving free Farxiga, you submit updated income documentation and a current prescription. Failure to renew before the expiration date interrupts your supply, so flag the renewal notice as soon as it arrives.
Alternatives If You Do Not Qualify for AZ&Me
Commercially insured patients who earn too much for AZ&Me should use the Farxiga savings card, which typically reduces the monthly copay to $0 for eligible enrollees, with limits per fill and per year. The card is available directly from farxiga.com and does not require income verification. Similar copay cards exist for Jardiance, Ozempic, Trulicity, and other diabetes drugs, so compare savings programs if your physician is still selecting medications.
Medicare Part D patients facing high out-of-pocket costs should enroll in the Medicare Extra Help program through the Social Security Administration and opt into the Medicare Prescription Payment Plan (M3P), which caps annual OOP at $2,100 in 2026 and spreads that cap over 12 monthly installments. Nonprofit copay foundations such as the PAN Foundation and HealthWell maintain diabetes and chronic kidney disease funds that sometimes cover Farxiga copays. Our NovoCare PAP guide and Novartis PAP guide describe parallel programs from other manufacturers.
Farxiga Patient Assistance vs the Savings Card
The Farxiga patient assistance program ships free medication for people who cannot afford Farxiga on any insurance. The Farxiga savings card reduces the copay on insurance-covered fills for people who already have commercial coverage. They are not interchangeable. If you are uninsured or on Medicare with high OOP exposure, AZ&Me is the right track. If you have commercial insurance, the savings card is faster.
Patients who recently lost employer coverage and have not yet enrolled in marketplace insurance often use AZ&Me as a bridge. The application is forgiving about transitional insurance gaps, and the 90-day supply cushion provides breathing room while you finalize longer-term coverage through healthcare.gov.
Frequently Asked Questions
Is the Farxiga patient assistance program free?
Yes. Qualifying patients receive Farxiga at no cost for up to 12 months at a time, with no application fees, shipping fees, or copays. AstraZeneca funds the AZ&Me program and operates it as a nonprofit.
How long does it take to get Farxiga through AZ&Me?
Complete applications are typically processed in two to four weeks. The first 90-day shipment arrives shortly after approval. Incomplete paperwork or missing income proof can extend the timeline by several weeks.
Can Medicare patients get Farxiga through AZ&Me?
Yes, in some cases. Medicare Part D patients who are not enrolled in full Extra Help and who face significant out-of-pocket exposure can qualify. Many Medicare patients pair AZ&Me with the 2026 Medicare Prescription Payment Plan (M3P) to stabilize their annual drug spending.
How much income disqualifies me from the Farxiga patient assistance program?
Uninsured applicants must earn at or below 400% of the federal poverty level, which is roughly $62,600 for a single-person household in 2026. Larger households have proportionally higher thresholds. Medicare applicants use a slightly different calculation based on drug spending.
Does the Farxiga patient assistance program require a doctor?
Yes. Your prescribing physician must complete the prescriber section of the enrollment form and sign it. Medication typically ships to the physician’s office, so ongoing coordination with your doctor’s staff is part of the process.
The Bottom Line
The Farxiga patient assistance program, run through AstraZeneca’s AZ&Me foundation, provides free 90-day shipments of Farxiga to uninsured patients up to 400% of the federal poverty level and to eligible Medicare Part D patients. Apply at azandmeapp.com or call 1-800-292-6363, coordinate with your prescribing physician, and submit proof of household income. Commercially insured patients should use the Farxiga savings card instead, and Medicare patients should combine AZ&Me with the 2026 M3P payment plan where it fits.